Current update on established and novel biomarkers in salivary gland carcinoma pathology and the molecular pathways involved

European Archives of Oto-Rhino-Laryngology

Volumn 266, Issue 3, 2009, Pages 333-341

  Stenner, Markus ^a   Klussmann, J Peter ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Immunohistochemistry; Molecular pathology; Prognostic markers; Salivary gland carcinoma

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; CASPASE; CYCLOOXYGENASE 2; ESTROGEN RECEPTOR; GEFITINIB; IMATINIB; INTERLEUKIN 6; INTERLEUKIN 8; K RAS PROTEIN; LAPATINIB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE RECEPTOR; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMAD4 PROTEIN; SOMATOMEDIN C RECEPTOR; STAT3 PROTEIN; SURVIVIN; TAMOXIFEN; TELOMERASE REVERSE TRANSCRIPTASE; TRASTUZUMAB;

APOPTOSIS; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CLINICAL TRIAL; DISEASE MARKER; DRUG EFFICACY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; NICK END LABELING; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; BIOLOGICAL MARKERS; CARCINOMA; CELL PROLIFERATION; GENES, P53; HUMANS; MIDDLE AGED; ONCOGENES; POINT MUTATION; PROLIFERATING CELL NUCLEAR ANTIGEN; SALIVARY GLAND NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 62549144842     PISSN: 09374477     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00405-008-0882-7     Document Type: Review

References (70)

1. Vander Poorten VL (2002) Salivary gland carcinoma-stepping up the prognostic ladder. University of Amsterdam, Amsterdam, p 222
2. Barnes L, Eveson JW, Reichart P et al (eds) (2005) Tumors of the salivary gland. In: Pathology and genetics. Head and neck tumors. World health organization classification of tumors. IARC Press, Lyon, 209-281
3. W Cheuk JK Chan 2007 Advances in salivary gland pathology Histopathology 51 1 1 20
4. H Luukkaa P Klemi I Leivo 2005 Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases Acta Otolaryngol 125 2 207 214
5. I Leivo 2006 Insights into a complex group of neoplastic disease: advances in histopathologic classification and molecular pathology of salivary gland cancer Acta Oncol 45 6 662 668 10.1080/02841860600801316
6. T Yamamoto N Tanigawa 2001 The role of survivin as a new target of diagnosis and treatment in human cancer Med Electron Microsc 34 207 212 10.1007/s007950100017
7. M Schmitz P Diestelkoetter B Weigle 2000 Generation of survivin-specific CD8CT effector cells by dendritic cells pulsed with protein or selected peptides Cancer Res 60 4845 4849
8. SF Preuss A Weinell M Molitor 2008 Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer Br J Cancer 98 3 627 632
9. O Ben-Izhak Z Laster S Araidy 2007 TUNEL-an efficient prognosis predictor of salivary malignancies Br J Cancer 96 7 1101 1106
10. RM Nagler H Kerner S Ben-Eliezer 2003 Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies Oncology 64 4 389 398 10.1159/000070298
11. RH Vonderheide WC Hahn JL Schultze 1999 The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes Immunity 10 673 679 10.1016/S1074-7613(00)80066-7
12. AJ Durkin PM Bloomston AS Rosemurgy 2003 Defining the role of the epidermal growth factor receptor in pancreatic cancer grown in vitro Am J Surg 186 431 436 10.1016/j.amjsurg.2003.07.008
13. RL Dodd NJ Slevin 2006 Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies Oral Oncol 42 8 759 769
14. J Harding B Burtness 2005 Cetuximab: an epidermal growth factor receptor chimeric human-murine monoclonal antibody Drugs Today (Barc) 41 107 127 10.1358/dot.2005.41.2.882662
15. M Mimeault RE Brand AA Sasson 2005 Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies Pancreas 31 4 301 316
16. M Vered E Braunstein A Buchner 2002 Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin Head Neck 24 632 636 10.1002/hed.10104
17. GD Yancopoulos M Klagsbrun J Folkman 1998 Vasculogenesis, angiogenesis, and growth factors: ephrins enter the fray at the border Cell 93 5 661 664
18. P Lequerica-Fernández A Astudillo JC de Vicente 2007 Expression of vascular endothelial growth factor in salivary gland carcinomas correlates with lymph node metastasis Anticancer Res 27 5B 3661 3666
19. KJ Cho SS Lee YS Lee 1999 Proliferating cell nuclear antigen and C-erbB-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands Head Neck 21 414 419 doi:10.1002/(SICI)1097-0347(199908)21:5<414::AID-HED6>3. 0.CO;2-M
20. A Skálová I Starek T Vanecek 2003 Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by immunofluorescence in situ hybridization and immunohistochemistry Histopathology 42 1 9 10.1046/j.1365-2559.2003.01600.x
21. A Skálová Starek V Kucerova 2001 Salivary duct carcinoma-highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression Pathol Res Pract 197 621 626 10.1078/0344-0338-00136
22. A Etges DS Pinto Jr LP Kowalski 2003 Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumor J Clin Pathol 56 12 914 918
23. M Jaehne KT Jäkel K Röser 2001 About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands-a pilot-study Laryngorhinootologie 80 525 529 10.1055/s-2001-17088
24. M Jaehne K Roeser T Jaekel 2005 Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases Cancer 103 12 2526 2533
25. H Dong C Bertler E Schneider 1997 Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times Cytometry 28 280 288 doi:10.1002/(SICI)1097-0320(19970801)28:4<280:: AID-CYTO2>3.0.CO;2-G
26. A Pich L Chiusa R Navone 2004 Prognostic relevance of cell proliferation in head and neck tumors Ann Oncol 15 9 1319 1329
27. K Triantafillidou J Dimitrakopoulos F Iordanidis 2006 Mucoepidermoid carcinoma of minor salivary glands: a clinical study of 16 cases and review of the literature Oral Dis 12 4 364 370
28. A Skálová H Lehtonen K von Boguslawsky 1994 Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections Hum Pathol 25 9 929 935 10.1016/0046-8177(94)90014-0
29. T Kiyoshima K Shima I Kobayashi 2001 Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands Oral Oncol 37 3 315 322 10.1016/S1368-8375(00)00083-X
30. H Luukkaa P Klemi I Leivo 2006 Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases Acta Oncol 45 6 669 675 10.1080/02841860500543208
31. S Nordgard G Franzen M Boysen 1997 Ki-67 as a prognostic marker in adenoid cystic carcinoma assessed with the monoclonal antibody MIB1 in paraffin sections Laryngoscope 107 4 531 536 10.1097/00005537-199704000-00019
32. HB Hellquist K Sundelin A Di Bacco 1997 Tumor growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL) J Pathol 181 323 329 doi:10.1002/(SICI)1096-9896(199703)181:3<323::AID-PATH780>3.0.CO;2-K
33. M Bhattacharyya NR Lemoine 2006 Gene therapy developments for pancreatic cancer Best Pract Res Clin Gastroenterol 20 2 285 298
34. HF Frierson Jr AK El-Naggar JB Welsh 2002 Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma Am J Pathol 161 4 1315 1323
35. TL Lee J Yeh J Friedman 2008 A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas Int J Cancer 122 9 1987 1998
36. M Dong Y Nio K Yamasawa 2003 p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer J Surg Oncol 82 111 120 10.1002/jso.10186
37. Y Yamamoto Y Kishimoto AK Virmani 1996 Mutations associated with carcinomas arising from pleomorphic adenomas of the salivary glands Hum Pathol 27 782 786 10.1016/S0046-8177(96)90449-9
38. KM Yamada M Araki 2001 Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis J Cell Sci 114 2375
39. S Tomozawa NH Tsuno E Sunami 2000 Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis, of colorectal cancer Br J Cancer 83 324 328 10.1054/bjoc.2000.1270
40. Y Araki S Okamura SP Hussain 2003 Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways Cancer Res 63 728 734
41. S Dori P Trougouboff R David A Buchner 2000 Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin Oral Oncol 36 450 453 10.1016/S1368-8375(00)00029-4
42. IW Dimery LA Jones RP Verjan AK Raymond H Goepfert WK Hong 1987 Estrogen receptors in normal salivary gland and salivary gland carcinoma Arch Otolaryngol Head Neck Surg 113 1082 1085
43. JP Jeannon JV Soames H Bell JA Wilson 1999 Immunohistochemical detection of oestrogen and progesterone receptors in human salivary gland tumours Clin Otolaryngol 24 1 52 54 10.1046/j.1365-2273.1999.00211.x
44. SM Nasser WC Faquin Y Dayal 2003 Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors Am J Clin Pathol 119 6 801 806 10.1309/RVTP1G0Q727WJUQD
45. K Ohshiro SK Rayala MD Williams R Kumar AK El-Naggar 2006 Biological role of estrogen receptor beta in salivary gland adenocarcinoma cells Clin Cancer Res 12 (20 Pt 1) 5994 5999
46. T Yoshimura T Sumida S Liu A Onishi S Shintani PY Desprez H Hamakawa 2007 Growth inhibition of human salivary gland tumor cells by introduction of progesterone (Pg) receptor and Pg treatment Endocr Relat Cancer 14 4 1107 1116 10.1677/erc.1.01253
47. A Jemal T Murray E Ward 2005 Cancer statistics, 2005 CA Cancer J Clin 55 10 30
48. G Gaudernack 2006 Prospects for vaccine therapy for pancreatic cancer Best Pract Res Clin Gastroenterol 20 2 299 314
49. D Campani I Esposito U Boggi 2001 Bcl-2 expression in pancreas development and pancreatic cancer progression J Pathol 194 4 444 450
50. H Friess Z Lu HU Graber 1998 Bax, but not bcl-2, influences the prognosis of human pancreatic cancer Gut 43 3 414 421
51. MN Younes YW Park YD Yazici 2006 Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model Mol Cancer Ther 5 11 2696 2705
52. DJ Slamon B Leyland-Jones S Shak 2001 Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 11 783 792 10.1056/NEJM200103153441101
53. M Agulnik EW Cohen RB Cohen 2007 Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands J Clin Oncol 25 25 3978 3984
54. MP Piechocki GH Yoo SK Dibbley 2006 Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu Int J Cancer 119 2 441 454
55. SJ Hotte EW Winquist E Lamont 2005 Imatinib mesylate in patients with adenoid cystic carcinoma of the salivary glands expressing c-kit: a Princess Margaret Hospital Phase II consortium study J Clin Oncol 23 3 585 590 10.1200/JCO.2005.06.125
56. T Ohta T Nagakawa Y Tsukioka 1993 Expression of argyrophilic nucleolar organizer regions in ductal adenocarcinoma of the pancreas and its relationship to prognosis Int J Pancreatol 13 3 193 200
57. C Ferrara G Tessari A Poletti 1999 Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 6 5 1117 1122
58. M Niedergethmann M Rexin R Hidenbrand 2002 Prognostic implication of routine, immunohistochemical and molecular staging in respectable pancreatic adenocarcinoma Am J Surg Pathol 26 1578 1587 10.1097/00000478-200212000-00005
59. V Stoll V Calleja G Vassaux 2005 Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer Gut 54 1 109 116
60. S Yamamoto Y Tomita Y Hoshida 2004 Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma Clin Cancer Res 10 2846 2850 10.1158/1078-0432.CCR-02-1441
61. A Takeda M Osaki K Adachi 2004 Role of the phosphatidylinositol 3-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines Pancreas 28 353 358 10.1097/00006676-200404000-00026
62. A Hakam Q Fang R Karl 2003 Coexpression of IGF-1R and c-Src proteins in human pancreatic ductal adenocarcinoma Dig Dis Sci 48 10 1972 1978
63. D Coppola 2000 Molecular prognostic markers in pancreatic cancer Cancer Contr 7 5 421 427
64. T Toyonaga K Nakano M Nagano 2003 Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer Cancer Lett 201 107 116 10.1016/S0304- 3835(03)00482-8
65. J Sun MA Blaskovich R Jove 2005 Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity Oncogene 24 20 3236 3245
66. ST Dergham MC Dugan FH Sarkar 1998 Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy J Hepatobiliary Pancreat Surg 5 3 269 272 10.1007/s005340050045
67. RE Wilentz GH Su JL Dai 2000 Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinoma Am J Pathol 156 1 37 43
68. LW Feurino WE Fisher U Bharadwaj 2006 Current update of cytokines in pancreatic cancer: pathogenic mechanisms, clinical indication, and therapeutic values Cancer Invest 24 7 696 703
69. X Le Q Shi B Wang 2000 Molecular regulation of constitutive expression of interleukin-8 in human pancreatic adenocarcinoma J Interferon Cytokine Res 20 935 10.1089/10799900050198372
70. A Shadaba MN Gaze HR Grant 1997 The response of adenoid cystic carcinoma to tamoxifen J Laryngol Otol 111 12 1186 1189 10.1017/S0022215100139684